13F HOLDINGS REPORT
COMMODORE CAPITAL LP
Quarter ended Q3 2024 · Filed November 14, 2024 · Accession 0001831942-24-000009
Total Value
$1.60B
Positions
36
Other Managers
0
Confidential Omitted
No
Holdings (36)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | MERUS N V | N5749R100 | 3,350,000 | $167.4M | 10.46% |
| 2 | VERA THERAPEUTICS INC | VERA | 2,475,000 | $109.4M | 6.84% |
| 3 | XENON PHARMACEUTICALS INC | XENE | 2,700,000 | $106.3M | 6.64% |
| 4 | VAXCYTE INC | PCVX | 920,000 | $105.1M | 6.57% |
| 5 | ENLIVEN THERAPEUTICS INC | ELVN | 4,100,000 | $104.7M | 6.54% |
| 6 | NUVALENT INC | NUVL | 940,000 | $96.2M | 6.01% |
| 7 | COGENT BIOSCIENCES INC | COGT | 7,539,930 | $81.4M | 5.09% |
| 8 | ALKERMES PLC | ALKS | 2,900,000 | $81.2M | 5.07% |
| 9 | SOLENO THERAPEUTICS INC | SLNO | 1,260,000 | $63.6M | 3.98% |
| 10 | SPYRE THERAPEUTICS INC | SYRE | 1,988,084 | $58.5M | 3.65% |
| 11 | VIRIDIAN THERAPEUTICS INC | VRDN | 2,550,124 | $58.0M | 3.63% |
| 12 | CELLDEX THERAPEUTICS INC NEW | CLDX | 1,618,937 | $55.0M | 3.44% |
| 13 | MIND MEDICINE MINDMED INC | 60255C885 | 8,000,000 | $45.5M | 2.84% |
| 14 | PERSPECTIVE THERAPEUTICS INC | CATX | 3,350,000 | $44.7M | 2.79% |
| 15 | NURIX THERAPEUTICS INC | NRIX | 1,650,000 | $37.1M | 2.32% |
| 16 | PHARVARIS N V | PHVS | 1,911,433 | $35.4M | 2.21% |
| 17 | KURA ONCOLOGY INC | KURA | 1,800,000 | $35.2M | 2.20% |
| 18 | RHYTHM PHARMACEUTICALS INC | RYTM | 650,000 | $34.1M | 2.13% |
| 19 | ORUKA THERAPEUTICS INC | ORKA | 1,369,714 | $33.6M | 2.10% |
| 20 | ARVINAS INC | ARVN | 1,200,000 | $29.6M | 1.85% |
| 21 | CELCUITY INC | CELC | 1,522,332 | $22.7M | 1.42% |
| 22 | CENTESSA PHARMACEUTICALS PLC | CNTA | 1,350,000 | $21.6M | 1.35% |
| 23 | NKARTA INC | NKTX | 4,662,073 | $21.1M | 1.32% |
| 24 | ORIC PHARMACEUTICALS INC | ORIC | 2,000,000 | $20.5M | 1.28% |
| 25 | C4 THERAPEUTICS INC | CCCC | 3,410,384 | $19.4M | 1.21% |
| 26 | THIRD HARMONIC BIO INC | 88427A107 | 1,360,569 | $18.4M | 1.15% |
| 27 | SYNDAX PHARMACEUTICALS INC | SNDX | 885,000 | $17.0M | 1.06% |
| 28 | APOGEE THERAPEUTICS INC | APGE | 290,000 | $17.0M | 1.06% |
| 29 | ABIVAX SA | AAVXF | 1,284,110 | $14.8M | 0.92% |
| 30 | INSTIL BIO INC | TIL | 150,929 | $10.2M | 0.63% |
| 31 | NEUROGENE INC | NGNE | 200,000 | $8.4M | 0.52% |
| 32 | PERCEPTIVE CAP SOLUTIONS COR | G70077105 | 750,000 | $7.5M | 0.47% |
| 33 | HELIX ACQUISITION CORP II | HLXC | 500,000 | $5.2M | 0.33% |
| 34 | CABALETTA BIO INC | CABA | 1,100,000 | $5.2M | 0.32% |
| 35 | VISTAGEN THERAPEUTICS INC | VTGN | 1,575,000 | $4.7M | 0.30% |
| 36 | AVALO THERAPEUTICS INC | AVTX | 483,000 | $4.6M | 0.29% |